10 Recruiting Gastrointestinal Stromal Tumors Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Gastrointestinal Stromal Tumors
Top Recruiting Gastrointestinal Stromal Tumors Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST
📍 Sylvester Comprehensive Cancer Center, University of Miami — Miami, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
📍 Mayo Clinic Scottsdale — Scottsdale, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
📍 University of Miami — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
📍 University of California, San Diego — La Jolla, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Imatinib TDM in GIST
📍 Markey Cancer Center — Lexington, Kentucky
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
📍 University of Michigan Hospitals — Ann Arbor, Michigan
View Study & Checklist ➔